Skip to main content
Top
Published in: BMC Medical Genetics 1/2018

Open Access 01-12-2018 | Case report

Neurodegeneration in an adolescent with Sjogren-Larsson syndrome: a decade-long follow-up case report

Authors: Kye Hee Cho, Sung Han Shim, Youngsoo Jung, Se Ra Sung, MinYoung Kim

Published in: BMC Medical Genetics | Issue 1/2018

Login to get access

Abstract

Background

Sjogren-Larsson syndrome is a hereditary neurocutaneous syndrome that is non-progressive in nature. Although neuroregression has been reported in seizure-prone preschool children requiring anti-epileptic treatment, teenage-onset dystonia precipitating neurodegeneration without any immediate causal events has yet to be reported.

Case presentation

We describe a young woman with spastic diplegia and intellectual disability who began to show progressive neurological deterioration from 12 years of age, with the onset of dystonia and tremor. She was initially diagnosed with spastic cerebral palsy and periventricular leukomalacia based on brain magnetic resonance imaging. Follow-up brain imaging from 13 years of age did not reveal apparent changes, though abnormal electroencephalographic findings occurred in parallel with her decline in motor function. By 19 years of age, she had developed dysphagia and became completely dependent on others for most activities of daily living. Ultimately, whole-exome sequencing revealed a heterozygous compound mutation in the ALDH3A2 gene that corresponds to Sjogren-Larsson syndrome: an exon 9 deletion (1291-1292delAA) from the mother and an exon 5 splicing mutation (798 + 1delG) from the father. Neuroregression has been reported in preschool children after seizures requiring treatment, though our patient did not experience any immediate causal events. This report summarizes the clinical, radiologic, and electrophysiological findings observed over a decade concurrent with neurological deterioration after the onset of dystonia and tremor at the age of developmental ceiling in Sjogren-Larsson syndrome.

Conclusions

In addition to the influence of additive variants or other environmental factors, accumulation of metabolites due to defective fatty aldehyde dehydrogenase is a potential pathomechanism of neurodegeneration in this patient. Neurological deterioration may be a presentation that is unnoticed in Sjogren-Larsson syndrome due to the rarity of the disease. This report highlights a unique clinical feature of Sjogren-Larsson syndrome with progressive neurodegeneration associated with dystonia and tremor.
Appendix
Available only for authorised users
Literature
1.
go back to reference Willemsen MA, IJlst L, Steijlen PM, Rotteveel JJ, de Jong JG, van Domburg PH, Mayatepek E, Gabreëls FJ, Wanders RJ. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren–Larsson syndrome. Brain. 2001;124(7):1426–37.CrossRefPubMed Willemsen MA, IJlst L, Steijlen PM, Rotteveel JJ, de Jong JG, van Domburg PH, Mayatepek E, Gabreëls FJ, Wanders RJ. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren–Larsson syndrome. Brain. 2001;124(7):1426–37.CrossRefPubMed
2.
go back to reference Fuijkschot J, Theelen T, Seyger MM, van der Graaf M, de Groot IJ, Wevers RA, Wanders RJ, Waterham HR, Willemsen MA. Sjogren-Larsson syndrome in clinical practice. J Inherit Metab Dis. 2012;35(6):955–62.CrossRefPubMed Fuijkschot J, Theelen T, Seyger MM, van der Graaf M, de Groot IJ, Wevers RA, Wanders RJ, Waterham HR, Willemsen MA. Sjogren-Larsson syndrome in clinical practice. J Inherit Metab Dis. 2012;35(6):955–62.CrossRefPubMed
3.
go back to reference Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, Dan B, Jacobsson B. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007;109(suppl 109):8–14.PubMed Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, Dan B, Jacobsson B. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007;109(suppl 109):8–14.PubMed
4.
go back to reference Rizzo WB, Carney G, Lin Z. The molecular basis of Sjogren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene. Am J Hum Genet. 1999;65(6):1547–60.CrossRefPubMedPubMedCentral Rizzo WB, Carney G, Lin Z. The molecular basis of Sjogren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene. Am J Hum Genet. 1999;65(6):1547–60.CrossRefPubMedPubMedCentral
5.
go back to reference Cho KH, Shim SH, Kim M. Clinical, biochemical, and genetic aspects of Sjogren-Larsson syndrome. Clin Genet. 2018;93(4):721–30.CrossRefPubMed Cho KH, Shim SH, Kim M. Clinical, biochemical, and genetic aspects of Sjogren-Larsson syndrome. Clin Genet. 2018;93(4):721–30.CrossRefPubMed
6.
go back to reference Rizzo WB. Sjogren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency. Mol Genet Metab. 2007;90(1):1–9.CrossRefPubMed Rizzo WB. Sjogren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency. Mol Genet Metab. 2007;90(1):1–9.CrossRefPubMed
7.
go back to reference Demozay D, Mas JC, Rocchi S, Van Obberghen E. FALDH reverses the deleterious action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal on insulin signaling in 3T3-L1 adipocytes. Diabetes. 2008;57(5):1216–26.CrossRefPubMed Demozay D, Mas JC, Rocchi S, Van Obberghen E. FALDH reverses the deleterious action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal on insulin signaling in 3T3-L1 adipocytes. Diabetes. 2008;57(5):1216–26.CrossRefPubMed
8.
go back to reference Zarkovic K. 4-Hydroxynonenal and neurodegenerative diseases. Mol Asp Med. 2003;24(4–5):293–303.CrossRef Zarkovic K. 4-Hydroxynonenal and neurodegenerative diseases. Mol Asp Med. 2003;24(4–5):293–303.CrossRef
9.
go back to reference Verhoog J, Fuijkschot J, Willemsen M, Ketelaar M, Rotteveel J, Gorter JW. Sjogren-Larsson syndrome: motor performance and everyday functioning in 17 patients. Dev Med Child Neurol. 2008;50(1):38–43.CrossRefPubMed Verhoog J, Fuijkschot J, Willemsen M, Ketelaar M, Rotteveel J, Gorter JW. Sjogren-Larsson syndrome: motor performance and everyday functioning in 17 patients. Dev Med Child Neurol. 2008;50(1):38–43.CrossRefPubMed
10.
11.
go back to reference Kariminejad A, Barzgar M, Bozorgmehr B, Keshavarz E, Kariminejad MH, S’Aulis D, Rizzo WB. Novel mutations and a severe neurological phenotype in Sjogren-Larsson syndrome patients from Iran. Eur J Med Genet. 2018;61(3):139–144. Kariminejad A, Barzgar M, Bozorgmehr B, Keshavarz E, Kariminejad MH, S’Aulis D, Rizzo WB. Novel mutations and a severe neurological phenotype in Sjogren-Larsson syndrome patients from Iran. Eur J Med Genet. 2018;61(3):139–144.
12.
go back to reference Davis K, Holden KR, S’Aulis D, Amador C, Matheus MG, Rizzo WB. Novel mutation in Sjogren-Larsson syndrome is associated with divergent neurologic phenotypes. J Child Neurol. 2013;28(10):1259–65.CrossRefPubMed Davis K, Holden KR, S’Aulis D, Amador C, Matheus MG, Rizzo WB. Novel mutation in Sjogren-Larsson syndrome is associated with divergent neurologic phenotypes. J Child Neurol. 2013;28(10):1259–65.CrossRefPubMed
13.
14.
go back to reference Rizzo WB, Carney G. Sjogren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2). Hum Mutat. 2005;26(1):1–10.CrossRefPubMed Rizzo WB, Carney G. Sjogren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2). Hum Mutat. 2005;26(1):1–10.CrossRefPubMed
15.
go back to reference Lossos A, Khoury M, Rizzo WB, Gomori JM, Banin E, Zlotogorski A, Jaber S, Abramsky O, Argov Z, Rosenmann H. Phenotypic variability among adult siblings with Sjogren-Larsson syndrome. Arch Neurol. 2006;63(2):278–80.CrossRefPubMedPubMedCentral Lossos A, Khoury M, Rizzo WB, Gomori JM, Banin E, Zlotogorski A, Jaber S, Abramsky O, Argov Z, Rosenmann H. Phenotypic variability among adult siblings with Sjogren-Larsson syndrome. Arch Neurol. 2006;63(2):278–80.CrossRefPubMedPubMedCentral
16.
Metadata
Title
Neurodegeneration in an adolescent with Sjogren-Larsson syndrome: a decade-long follow-up case report
Authors
Kye Hee Cho
Sung Han Shim
Youngsoo Jung
Se Ra Sung
MinYoung Kim
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2018
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/s12881-018-0663-0

Other articles of this Issue 1/2018

BMC Medical Genetics 1/2018 Go to the issue